Ytrehus K, Walsh R S, Richards S C, Downey J M
Dept. of Medical Physiology, University of Tromsø, Norway.
Cardiovasc Res. 1995 Dec;30(6):1033-7.
In spite of extensive research during the last decade it has not been possible to prove that endogenously generated hydrogen peroxide or any reduced oxygen species reaches sufficient concentration during reperfusion after myocardial ischemia to contribute significantly to irreversible cell injury. In an attempt to further test this hypothesis we subjected isolated perfused rabbit hearts to 30 min regional ischemia followed by reperfusion and supplied hydrogen peroxide in low levels with or without catalase during the first 30 min of reperfusion and thereafter continued the reperfusion for a total of 120 min. Five different groups were studied: controls, and hearts supplied with 2 microM H2O2, 1 microM H2O2, 1 microM H2O2 + catalase (IU/l) or catalase alone in the initial part of the reperfusion. At the end of 120 min reperfusion, area at risk was measured with fluorescent particles and infarct zone size with tetrazolium staining. The results were: in the control group 32 +/- 5.0% of the risk zone infarcted, in the 2 microM H2O2 group 16.3 +/- 5.6% and in the 1 microM H2O2 group 6.9 +/- 0.8% (P < 0.05 compared to control). The reduction in infarct size was not present when catalase was added to the hydrogen peroxide-containing solution (26.4 +/- 4.5) or if catalase was present alone (22.9 +/- 1.8% infarction). In conclusion, hydrogen peroxide, 1 microM, protected the heart during reperfusion and reduced the amount of cell death after 120 min of reperfusion. The study demonstrated reduction or delay in infarction based only on treatment in the reperfusion period. The mechanism behind this protection remains to be determined.
尽管在过去十年中进行了广泛的研究,但仍无法证明内源性产生的过氧化氢或任何还原氧物种在心肌缺血后的再灌注过程中能达到足够的浓度,从而对不可逆的细胞损伤有显著影响。为了进一步验证这一假设,我们对离体灌注的兔心脏进行了30分钟的局部缺血,然后进行再灌注,并在再灌注的前30分钟内以低水平供应过氧化氢,同时添加或不添加过氧化氢酶,之后继续再灌注120分钟。研究了五个不同的组:对照组,以及在再灌注初始阶段供应2微摩尔过氧化氢、1微摩尔过氧化氢、1微摩尔过氧化氢 + 过氧化氢酶(国际单位/升)或仅供应过氧化氢酶的心脏。在再灌注120分钟结束时,用荧光颗粒测量危险区域面积,用四氮唑染色测量梗死区域大小。结果显示:对照组中有32 ± 5.0%的危险区域发生梗死,在2微摩尔过氧化氢组中为16.3 ± 5.6%,在1微摩尔过氧化氢组中为6.9 ± 0.8%(与对照组相比,P < 0.05)。当向含过氧化氢的溶液中添加过氧化氢酶时(梗死率为26.4 ± 4.5),或仅存在过氧化氢酶时(梗死率为22.9 ± 1.8%),梗死面积没有减少。总之,1微摩尔的过氧化氢在再灌注期间保护了心脏,并减少了再灌注120分钟后的细胞死亡量。该研究表明,仅在再灌注期进行治疗就能减少或延迟梗死。这种保护作用背后的机制仍有待确定。